<?xml version="1.0" encoding="ISO-8859-1" ?>
<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/shared/bsp/xsl/rss/nolsol.xsl"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Efficacy and Mechanism Evaluation Programme News</title>
    <link>http://www.eme.ac.uk/news_and_events/</link>
    <description>Get the latest Efficacy and Mechanism Evaluation Programme News</description>
    <language>en-gb</language>
    <copyright>Copyright: (C) NIHR Efficacy and Mechanism Evaluation Programme, see http://www.eme.ac.uk/legal/copyright.asp for terms and conditions of reuse</copyright>
    <ttl>60</ttl>
	    <image>
      <title>Efficacy and Mechanism Evaluation Programme News</title>
      <url>http://www.eme.ac.uk/media/furniture/header_print.gif</url>
      <link>http://www.eme.ac.uk/news_and_events/</link>
    </image>
	
	<item>
      <title>Comparison of radiotherapy techniques for breast cancer</title>
      <description>A new study comparing standard imaging and image guided radiotherapy (IGRT) for the treatment of breast cancer has been funded by the EME programme.</description>
      <link>http://www.eme.ac.uk/news_and_events/</link>
	  <pubDate>Wed, 16 Mar 2011 15:30:00 GMT</pubDate>
      <category>Health</category>
      </item>
	
	
	
	 <item>
      <title>Research begins patient trials of new Leukaemia cancer vaccine</title>
      <description>A new cancer treatment which strengthens a patient's immune system and could enable them to fight the disease more effectively is trialling for the first time in the UK. It has been funded by the EME programme in addition to the charity Leukaemia and Lymphoma Research.</description>
      <link>http://www.eme.ac.uk/news_and_events/</link>
	  <pubDate>Mon, 31 Jan 2011 13:11:00 GMT</pubDate>
      <category>Health</category>
      </item>	

<item>
      <title>New funding stream for translational medicine</title>
      <description>The National Institute for Health Research (NIHR) is to launch a new, commissioned, workstream for the Efficacy and Mechanism Evaluation (EME) programme. The new commissioned workstream is funded by NIHR, with contributions from the CSO in Scotland and NISCHR in Wales. It will complement the established MRC funded EME researcher-led workstream which funds research into the efficacy and broader impact of healthcare treatments and tests.</description>
      <link>http://www.eme.ac.uk/news_and_events/</link>
	  <pubDate>Wed, 29 Jun 2011 15:35:00 GMT</pubDate>
      <category>Health</category>
      </item>	
   
  </channel>
</rss>

